Adtran and 6WIND partner to deliver scalable vBNG and vCGNAT solutions for end-to-end broadband networks
9.4.2025 09:00:00 CEST | Business Wire | Press Release
Adtran today announced its partnership with 6WIND to deliver scalable virtual broadband network gateway (vBNG) and virtual carrier-grade NAT (vCGNAT) solutions, giving service providers a more agile and cost-effective way to manage subscriber authentication, routing and traffic handling. By integrating 6WIND’s vBNG and vCGNAT into Adtran’s Mosaic software suite, service providers can replace expensive, hardware-based BNGs with a software-driven alternative that scales on demand without sacrificing performance. This collaboration strengthens Adtran’s end-to-end solution, enabling seamless broadband service delivery while reducing expense and complexity for operators.
“Virtualization is transforming network infrastructure and service providers need high-performance, scalable solutions to stay competitive,” said Julien Dahan, CEO of 6WIND. “By integrating our vBNG and vCGNAT with Adtran’s Mosaic software suite, we’re delivering a cloud-native alternative to legacy hardware that lowers costs and boosts efficiency. This collaboration enables providers to deploy virtualized broadband services with carrier-grade performance while streamlining operations. Together, we’re providing a complete solution that enhances network agility while lowering overheads, helping providers deploy and manage broadband services more efficiently than ever.”
By running as a virtual machine (VM) on commercial off-the-shelf servers, 6WIND’s vBNG and vCGNAT eliminate the need for costly, proprietary hardware. Adtran has integrated the solution with its Mosaic software suite and line-rate traffic management within its fiber access platforms, enabling non-blocking BNG performance at multigigabit speeds while automating provisioning, authentication and subscriber monitoring – all without requiring specialized integration. Designed for scalability, this architecture supports everything from small networks to deployments serving millions of subscribers. It also supports key broadband functions, including RADIUS authentication, CGNAT and dynamic routing, while ensuring carrier-grade performance with low latency and high throughput. Unlike traditional hardware appliances from other vendors that require expensive, fixed-capacity hardware, this virtualized approach allows operators to scale from thousands to millions of subscribers with minimal investment.
“Today’s service providers require more than standalone solutions – they need a fully integrated network that scales efficiently. By combining 6WIND’s high-performance vBNG and vCGNAT with our software applications and fiber access platforms, we’re giving operators an affordable and highly flexible alternative to traditional BNGs,” commented Robert Conger, GM of software platforms and strategy at Adtran. “This partnership builds on our long-standing collaboration, which has already delivered more than 12,000 6WIND routers as the Ensemble vRouter, with hundreds more deployed each month. Together, we’re simplifying operations and giving providers greater control over their networks. And because we provide integration, deployment support and professional services, we make it even easier for our customers to scale and optimize their networks while delivering high-quality connectivity.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the majority shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
About 6WIND
6WIND leads the way in virtualized and cloud-native networking software solutions. Specializing in high-performance and efficiency, 6WIND’s products enable service providers and enterprises to build and manage efficient, scalable, secure, and sustainable networks. Our offerings span Broadband Evolution, Cloud Connectivity, Mobile Network Security, 5G SA Enablement, B2B services, AI-RAN Enablement and more, ensuring comprehensive solutions for diverse use cases. For more information, please visit www.6wind.com.
Published by
ADTRAN Holdings, Inc.
www.adtran.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20250408700151/en/
Contacts
For media
Gareth Spence
+44 1904 699 358
public.relations@adtran.com
For investors
Peter Schuman
+1 256 963 6305
investor.relations@adtran.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom